These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 400737)

  • 1. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
    Sacca L; Hendler R; Sherwin RS
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1160-3. PubMed ID: 400737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
    Felig P; Wahren J; Hendler R
    J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical training in juvenile diabetes.
    Koivisto VA; Groop L
    Ann Clin Res; 1982; 14 Suppl 34():74-9. PubMed ID: 6756276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucoregulatory response to intravenous glucose infusion in normal man: roles of insulin and glucose.
    Saccà L; Vitale D; Cicala M; Trimarco B; Ungaro B
    Metabolism; 1981 May; 30(5):457-61. PubMed ID: 6112655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
    Eigler N; Saccà L; Sherwin RS
    J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man.
    Ward WK; Best JD; Halter JB; Porte D
    J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
    Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D
    J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-glucagon interaction in controlling splanchnic glucose production in normal man.
    Bomboy JD; Lewis SB; Sinclair-Smith BC; Lacy WW; Liljenquist JE
    J Clin Endocrinol Metab; 1977 Mar; 44(3):474-80. PubMed ID: 838848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of hepatic glucose output by glucagon and insulin in the intact dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Lacy WW; Park CR
    Biochem Soc Symp; 1978; (43):31-45. PubMed ID: 373768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tolbutamide and hepatic extraction of insulin and glucagon and hepatic glucose output in anesthetized dogs.
    Ishida T; Chou MC; Lewis RM; Hartley CJ; Entman M; Field JB
    Endocrinology; 1981 Aug; 109(2):443-50. PubMed ID: 7018888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
    Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
    J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-endorphin inhibits glucose production in the conscious dog.
    Radosevich PM; Williams PE; McRae JR; Lacy WW; Orth DN; Abumrad NN
    J Clin Invest; 1984 Apr; 73(4):1237-41. PubMed ID: 6323537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.